1	Un	Un		C0205447_1	calificador_1	0-2	647_QUEST_clinical_caseMIR	SENT1	-	-
2	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	3-9	647_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	10-12	647_QUEST_clinical_caseMIR	SENT1	-	-
4	70	70		-	-	13-15	647_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	16-20	647_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0001779_1	entidad_observable_1	21-23	647_QUEST_clinical_caseMIR	SENT1	-	-
7	edad	edad	NCFS000	C0001779_2	entidad_observable_2	24-28	647_QUEST_clinical_caseMIR	SENT1	-	-
8	acude	acudir	VMIP3S0	-	-	29-34	647_QUEST_clinical_caseMIR	SENT1	-	-
9	a	a	SPS00	-	-	35-36	647_QUEST_clinical_caseMIR	SENT1	-	-
10	revisión	revisión	NCFS000	C0558347_1	procedimiento_1	37-45	647_QUEST_clinical_caseMIR	SENT1	-	-
11	tras	tras	SPS00	-	-	46-50	647_QUEST_clinical_caseMIR	SENT1	-	-
12	el	el	DA0MS0	-	-	51-53	647_QUEST_clinical_caseMIR	SENT1	-	-
13	alta	alto	AQ0FS0	C0205250	calificador	54-58	647_QUEST_clinical_caseMIR	SENT1	-	-
14	reciente	reciente	AQ0CS0	C0332185	calificador	59-67	647_QUEST_clinical_caseMIR	SENT1	-	-
15	por	por	SPS00	C0678226	atributo	68-71	647_QUEST_clinical_caseMIR	SENT1	-	-
16	un	un		C0205447_1	calificador_1	72-74	647_QUEST_clinical_caseMIR	SENT1	-	-
17	episodio	episodio	NCMS000	C0332189#C1455761_1	atributo_1	75-83	647_QUEST_clinical_caseMIR	SENT1	-	-
18	de	de	SPS00	C0332189#C1455761_2	atributo_2	84-86	647_QUEST_clinical_caseMIR	SENT1	-	-
19	insuficiencia	insuficiencia	NCFS000	C0231179	hallazgo	87-100	647_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
20	cardiaca	cardiaco	AQ0FS0	-	-	101-109	647_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
21	de	de	SPS00	C0332285	atributo	110-112	647_QUEST_clinical_caseMIR	SENT1	-	-
22	posible	posible	AQ0CS0	C0332149#C2362652	calificador	113-120	647_QUEST_clinical_caseMIR	SENT1	-	-
23	etiología	etiología	NCFS000	C1314792	atributo	121-130	647_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	Especulacion
24	isquémica	isquémico	AQ0FS0	C0475224	calificador	131-140	647_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
25	.	.	Fp	-	-	140-141	647_QUEST_clinical_caseMIR	SENT1	-	-

1	Presenta	presentar	VMIP3S0	-	-	142-150	647_QUEST_clinical_caseMIR	SENT2	-	-
2	una	una		C0205447_1	calificador_1	151-154	647_QUEST_clinical_caseMIR	SENT2	-	-
3	disnea	disnea	NCFS000	C0013404#C0553668	hallazgo	155-161	647_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
4	a	a	SPS00	-	-	162-163	647_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
5	mínimos	mínimo	NCMP000	C0547040#C1282907	calificador	164-171	647_QUEST_clinical_caseMIR	SENT2	I-Calificador	-
6	esfuerzos	esfuerzo	NCMP000	-	-	172-181	647_QUEST_clinical_caseMIR	SENT2	I-Calificador	-
7	(	(	Fpa	-	-	182-183	647_QUEST_clinical_caseMIR	SENT2	-	-
8	clase	clase	NCFS000	C0456387	atributo	183-188	647_QUEST_clinical_caseMIR	SENT2	-	-
9	funcional	funcional	AQ0CS0	C0205245	calificador	189-198	647_QUEST_clinical_caseMIR	SENT2	-	-
10	III	iii	RG	-	-	199-202	647_QUEST_clinical_caseMIR	SENT2	-	-
11	de	de	SPS00	C0332285	atributo	203-205	647_QUEST_clinical_caseMIR	SENT2	-	-
12	la	el	DA0FS0	-	-	206-208	647_QUEST_clinical_caseMIR	SENT2	-	-
13	New	new	NCMS000	-	-	209-212	647_QUEST_clinical_caseMIR	SENT2	-	-
14	York	york	AQ0CN00	-	-	213-217	647_QUEST_clinical_caseMIR	SENT2	-	-
15	Heart	heart	NCMS000	-	-	218-223	647_QUEST_clinical_caseMIR	SENT2	-	-
16	Association	association	NCCN000	-	-	224-235	647_QUEST_clinical_caseMIR	SENT2	-	-
17	)	)	Fpt	-	-	235-236	647_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	236-237	647_QUEST_clinical_caseMIR	SENT2	-	-

1	Los	el	DA0MP0	-	-	238-241	647_QUEST_clinical_caseMIR	SENT3	-	-
2	medicamentos	medicamento	NCMP000	C0456386#C0013227	atributo#sustancia	242-254	647_QUEST_clinical_caseMIR	SENT3	-	-
3	al	al	SP+DA	-	-	255-257	647_QUEST_clinical_caseMIR	SENT3	-	-
4	alta	alto	AQ0FS0	C0205250	calificador	258-262	647_QUEST_clinical_caseMIR	SENT3	-	-
5	incluyen	incluir	VMIP3P0	-	-	263-271	647_QUEST_clinical_caseMIR	SENT3	-	-
6	carvedilol	carvedilol	NCMS000	C0054836	producto#sustancia	272-282	647_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
7	25	25	Z	-	-	283-285	647_QUEST_clinical_caseMIR	SENT3	-	-
8	mg	mg	NCMN000	-	-	286-288	647_QUEST_clinical_caseMIR	SENT3	-	-
9	cada	cada	NC00SC0	C0456695_1	calificador_1	289-293	647_QUEST_clinical_caseMIR	SENT3	-	-
10	12	12	Z	C0456695_2	calificador_2	294-296	647_QUEST_clinical_caseMIR	SENT3	-	-
11	horas	hora	NCFP000	C0456695_3	calificador_3	297-302	647_QUEST_clinical_caseMIR	SENT3	-	-
12	,	,	Fc	-	-	302-303	647_QUEST_clinical_caseMIR	SENT3	-	-
13	enalapril	enalapril	NC00SC0	C0014025	sustancia	304-313	647_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
14	20	20	Z	-	-	314-316	647_QUEST_clinical_caseMIR	SENT3	-	-
15	mg	mg	NCMN000	-	-	317-319	647_QUEST_clinical_caseMIR	SENT3	-	-
16	al	al	SP+DA	-	-	320-322	647_QUEST_clinical_caseMIR	SENT3	-	-
17	día	día	NCMS000	C0439228#C0332169	calificador	323-326	647_QUEST_clinical_caseMIR	SENT3	-	-
18	,	,	Fc	-	-	326-327	647_QUEST_clinical_caseMIR	SENT3	-	-
19	furosemida	furosemida	NC00SC0	C0016860	producto#sustancia	328-338	647_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
20	40	40	Z	-	-	339-341	647_QUEST_clinical_caseMIR	SENT3	-	-
21	mg	mg	NCMN000	-	-	342-344	647_QUEST_clinical_caseMIR	SENT3	-	-
22	al	al	SP+DA	-	-	345-347	647_QUEST_clinical_caseMIR	SENT3	-	-
23	día	día	NCMS000	C0439228#C0332169	calificador	348-351	647_QUEST_clinical_caseMIR	SENT3	-	-
24	.	.	Fp	-	-	351-352	647_QUEST_clinical_caseMIR	SENT3	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	353-355	647_QUEST_clinical_caseMIR	SENT4	-	-
2	la	el	DA0FS0	-	-	356-358	647_QUEST_clinical_caseMIR	SENT4	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	359-370	647_QUEST_clinical_caseMIR	SENT4	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	371-377	647_QUEST_clinical_caseMIR	SENT4	-	-
5	,	,	Fc	-	-	377-378	647_QUEST_clinical_caseMIR	SENT4	-	-
6	frecuencia	frecuencia	NCFS000	C0439603#C0376249	calificador#atributo	379-389	647_QUEST_clinical_caseMIR	SENT4	-	-
7	cardiaca	cardiaco	AQ0FS0	-	-	390-398	647_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
8	65	65		-	-	399-401	647_QUEST_clinical_caseMIR	SENT4	-	-
9	lpm	lpm	NC00YL0	-	-	402-405	647_QUEST_clinical_caseMIR	SENT4	-	-
10	,	,	Fc	-	-	405-406	647_QUEST_clinical_caseMIR	SENT4	-	-
11	presión	presión	NCFS000	C0005823#C1272641_1	entidad_observable_1	407-414	647_QUEST_clinical_caseMIR	SENT4	-	-
12	arterial	arterial	NC00SC0	C0005823#C1272641_2	entidad_observable_2	415-423	647_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
13	110/60	110/60	Z	-	-	424-430	647_QUEST_clinical_caseMIR	SENT4	-	-
14	mmHg	mmHg	NCMP000	-	-	431-435	647_QUEST_clinical_caseMIR	SENT4	-	-
15	.	.	Fp	-	-	435-436	647_QUEST_clinical_caseMIR	SENT4	-	-

1	No	no	RN	C1298908	calificador	437-439	647_QUEST_clinical_caseMIR	SENT5	-	-
2	tiene	tener	VMIP3S0	-	-	440-445	647_QUEST_clinical_caseMIR	SENT5	-	-
3	edemas	edema	NCMP000	C0013604	anomalía_morfológica#hallazgo#entidad_observable	446-452	647_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	Negacion
4	.	.	Fp	-	-	452-453	647_QUEST_clinical_caseMIR	SENT5	-	-

1	Analítica	analítica	NCFS000	-	-	454-463	647_QUEST_clinical_caseMIR	SENT6	-	-
2	:	:	Fd	-	-	463-464	647_QUEST_clinical_caseMIR	SENT6	-	-
3	creatinina	creatinina	NC00SC0	C0010294	sustancia	465-475	647_QUEST_clinical_caseMIR	SENT6	-	-
4	1,3	1.3	Z	-	-	476-479	647_QUEST_clinical_caseMIR	SENT6	-	-
5	mg	mg	NCMN000	-	-	480-482	647_QUEST_clinical_caseMIR	SENT6	-	-
6	/	/	Fh	-	-	482-483	647_QUEST_clinical_caseMIR	SENT6	-	-
7	dL	decilitro	NCMN000	C0439241	calificador	483-485	647_QUEST_clinical_caseMIR	SENT6	-	-
8	;	;	Fx	-	-	485-486	647_QUEST_clinical_caseMIR	SENT6	-	-
9	sodio	sodio	NCMS000	C3536896#C0037473	producto#sustancia	487-492	647_QUEST_clinical_caseMIR	SENT6	-	-
10	139	139		-	-	493-496	647_QUEST_clinical_caseMIR	SENT6	-	-
11	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	497-500	647_QUEST_clinical_caseMIR	SENT6	-	-
12	/	/	Fh	-	-	500-501	647_QUEST_clinical_caseMIR	SENT6	-	-
13	L	l	NCFS000	-	-	501-502	647_QUEST_clinical_caseMIR	SENT6	-	-
14	y	y	CC	C1706368	calificador	503-504	647_QUEST_clinical_caseMIR	SENT6	-	-
15	potasio	potasio	NCMS000	C0032821	sustancia#producto	505-512	647_QUEST_clinical_caseMIR	SENT6	-	-
16	3,9	3,9		-	-	513-516	647_QUEST_clinical_caseMIR	SENT6	-	-
17	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	517-520	647_QUEST_clinical_caseMIR	SENT6	-	-
18	/	/	Fh	-	-	520-521	647_QUEST_clinical_caseMIR	SENT6	-	-
19	L.	l.	NCFS000	-	-	521-523	647_QUEST_clinical_caseMIR	SENT6	-	-
20	¿	¿	Fia	-	-	524-525	647_QUEST_clinical_caseMIR	SENT6	-	-
21	Cuál	cuál	PT0CS000	-	-	525-529	647_QUEST_clinical_caseMIR	SENT6	-	-
22	de	de	SPS00	C0332285	atributo	530-532	647_QUEST_clinical_caseMIR	SENT6	-	-
23	las	el	DA0FP0	-	-	533-536	647_QUEST_clinical_caseMIR	SENT6	-	-
24	siguientes	siguiente	AQ0CP0	C0332282	atributo	537-547	647_QUEST_clinical_caseMIR	SENT6	-	-
25	medidas	medida	NCFP000	C0079809	atributo	548-555	647_QUEST_clinical_caseMIR	SENT6	-	-
26	es	ser	VSIP3S0	-	-	556-558	647_QUEST_clinical_caseMIR	SENT6	-	-
27	la	lo	PP3FSA00	C0205393_1	calificador_1	559-561	647_QUEST_clinical_caseMIR	SENT6	-	-
28	más	más	RG	C0205393_2	calificador_2	562-565	647_QUEST_clinical_caseMIR	SENT6	-	-
29	apropiada	apropiar	VMP00SF	-	-	566-575	647_QUEST_clinical_caseMIR	SENT6	-	-
30	para	para	SPS00	C0521125	calificador	576-580	647_QUEST_clinical_caseMIR	SENT6	-	-
31	este	este	DD0MS0	-	-	581-585	647_QUEST_clinical_caseMIR	SENT6	-	-
32	paciente	paciente	NCCS000	C0030705	persona	586-594	647_QUEST_clinical_caseMIR	SENT6	-	-
33	?	?	Fit	-	-	594-595	647_QUEST_clinical_caseMIR	SENT6	-	-
34	.	.	Fp	-	-	595-596	647_QUEST_clinical_caseMIR	SENT6	-	-

